Literature DB >> 11111095

Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake.

B L Trigatti1, A Rigotti, A Braun.   

Abstract

High-density lipoproteins (HDL) play an important role in protection against atherosclerosis by mediating reverse cholesterol transport - the transport of excess cholesterol from peripheral tissues to the liver for disposal. SR-BI is a cell surface receptor for HDL and other lipoproteins (LDL and VLDL) and mediates the selective uptake of lipoprotein cholesterol by cells. Overexpression or genetic ablation of SR-BI in mice revealed that it plays an important role in HDL metabolism and reverse cholesterol transport and protects against atherosclerosis in mouse models of the disease. If it plays a similar role in humans then it may be an attractive target for therapeutic intervention. We will review some of the recent advances in the understanding of SR-BI's physiological role and cellular function in lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11111095     DOI: 10.1016/s1388-1981(00)00154-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 2.  Why targeting HDL should work as a therapeutic tool, but has not.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

Review 3.  Human ocular carotenoid-binding proteins.

Authors:  Binxing Li; Preejith Vachali; Paul S Bernstein
Journal:  Photochem Photobiol Sci       Date:  2010-09-03       Impact factor: 3.982

4.  Scavenger receptor class B type I (SR-BI) in pig enterocytes: trafficking from the brush border to lipid droplets during fat absorption.

Authors:  G H Hansen; L-L Niels-Christiansen; L Immerdal; E M Danielsen
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

5.  Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.

Authors:  Björn Gustafsson; Susan Youens; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

6.  Generation of infectious HCV pseudo typed particles and its utilization for studying the role of CD81 & SRBI receptors in HCV infection.

Authors:  Shazia Rafique; Muhammad Idrees; Amjad Ali; Kashif Iqbal Sahibzada; Muhammad Iqbal
Journal:  Mol Biol Rep       Date:  2014-02-19       Impact factor: 2.316

Review 7.  Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease.

Authors:  Paul S Bernstein; Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Rajalekshmy Shyam; Bradley S Henriksen; John M Nolan
Journal:  Prog Retin Eye Res       Date:  2015-11-02       Impact factor: 21.198

8.  Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I.

Authors:  Sharookh B Kapadia; Heidi Barth; Thomas Baumert; Jane A McKeating; Francis V Chisari
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

9.  Impact of gene variants on sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study.

Authors:  Ornit Chiba-Falek; Marshall Nichols; Sunil Suchindran; John Guyton; Geoffrey S Ginsburg; Elizabeth Barrett-Connor; Jeanette J McCarthy
Journal:  BMC Med Genet       Date:  2010-01-19       Impact factor: 2.103

Review 10.  Hepatitis C Virus entry: the early steps in the viral replication cycle.

Authors:  Ali Sabahi
Journal:  Virol J       Date:  2009-07-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.